Home/ Stocks/ RZLT

Rezolute, Inc. Common Stock (NV)

RZLT XNAS

$3.88 +0.19 (+5.22%) ▲ 15-min delayed

Open

$3.67

High

$3.90

Low

$3.59

Volume

1.52M

Market Cap

$375.31M

About Rezolute, Inc. Common Stock (NV)

Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 58 Website →

Related Market News

No specific coverage for RZLT yet. Check out our latest market news or earnings calendar.

Get RZLT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Rezolute, Inc. Common Stock (NV).

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.